NCT06993662 The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06963034 NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia Status RECRUITING Phase PHASE3
NCT06961968 Randomized Withdrawal Study in Patients With Schizophrenia Status RECRUITING Phase PHASE3
NCT06961916 Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2) Status RECRUITING Phase NA
NCT06945627 Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06939088 Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder Status RECRUITING Phase PHASE2
NCT06923891 An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients Status NOT_YET_RECRUITING Phase PHASE4
NCT06904079 Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents Status RECRUITING Phase NA
NCT06894212 A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia Status RECRUITING Phase PHASE3
NCT06890208 Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave Status COMPLETED Phase N/A
NCT06889025 Therapeutic Improvement in People With Schizophrenia Undergoing tACS/CBTp (Transcranial Alternating Current Stimulation Applied Pre-cognitive Behavioral Therapy for Psychosis) Associated to Usual Medication Regimen Status NOT_YET_RECRUITING Phase NA
NCT06882785 A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia Status RECRUITING Phase PHASE3
NCT06880796 Mindfulness-Based Therapy for Serious Mental Illness Status ENROLLING_BY_INVITATION Phase NA
NCT06880328 18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia Status COMPLETED Phase PHASE1
NCT06878833 A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder Status WITHDRAWN Phase PHASE3
NCT06859112 The Effect of Logotherapy-Based Psychoeducation Applied to Family Members of Individuals Diagnosed with Schizophrenia on Finding Meaning, Hope and Depression Status NOT_YET_RECRUITING Phase NA